T-cell Therapy in Combination With Nivolumab, Relatlimab and Ipilimumab for Patients With Metastatic Ovarian Cancer
Herlev Hospital
Herlev Hospital
M.D. Anderson Cancer Center
Sumitomo Pharma America, Inc.
Fate Therapeutics
Duke University
ExcellaBio LLC